Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor receptors (FGFRs) are a family of receptor tyrosine kinases that play essential roles in cell signaling, development, and disease. "Pan-FGFR" refers to agents or analyses that target or consider all four main FGFR family members: FGFR1, FGFR2, FGFR3, and FGFR4. Dysregulation of FGFR signaling is implicated in various cancers, making them a therapeutic target. Pan-FGFR inhibitors show efficacy against tumors harboring activating genomic changes but may be associated with resistance mechanisms.
Small molecules inhibiting kinase activity across multiple FGFR family members.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast Growth Factor Receptors (Pan-FGFR) (Pan-FGFR).